Yervoy (ipilimumab) - BMS
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Actemra IV (tocilizumab) - Roche, JW Pharma, Chugai Pharmaceutical
Keytruda (pembrolizumab) - Merck (MSD)
Development and Analysis of a Stool Bank for Cancer Patients (clinicaltrials.gov) - Sep 19, 2026 - P=N/A | N=100 | Enrolling by invitation | Sponsor: Persephone Biosciences | Recruiting ➔ Enrolling by invitation 
Enrollment status • Colorectal Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
http://clinicaltrials.gov/ct2/show/NCT04291755
 
Sep 19, 2026
 
Prev Next